Microbial Stresses on Human Umbilical Cord Stem Cells

Area of Science:

• Stem Cell Biology
• Microbiology
• Immunology

Background:

• Umbilical cord blood and cord tissue are valuable, ethically unproblematic sources of mesenchymal stem cells (MSCs) and hematopoietic stem cells.
• Microorganism-stem cell interactions significantly influence stem cell functions, including self-renewal, differentiation, secretion, and cell death.
• Limited research exists on the interplay between pathogenic/commensal bacteria and umbilical cord-derived MSCs.

Purpose of the Study:

• To review the impact of microbial stresses on human umbilical cord stem cells.
• To elucidate the complex relationship between bacteria and MSCs, considering factors like bacterial load and immune cell presence.
• To discuss how bacterial pathogens and MSCs modulate each other's functions.

Main Methods:

• Literature review of studies investigating microorganism-stem cell interactions.
• Analysis of how bacterial factors (e.g., hypoxia, oxidative stress) affect MSC phenotype, development, and viability.
• Examination of MSCs' anti-inflammatory and antibacterial effects in response to varying bacterial loads and infection stages.

Main Results:

• Bacterial pathogens can alter MSC regenerative capacity by inducing stress factors like hypoxia and oxidative stress, affecting MSC phenotype and viability.
• MSCs exhibit anti-inflammatory and antibacterial properties, which are enhanced at high bacterial loads but diminished at low loads.
• The efficacy of MSC antibacterial effects varies with infection timing, being stronger early on and weaker in later stages with high inflammation and bacterial counts.

Conclusions:

• Microbial factors present significant stress to human umbilical cord stem cells, influencing their fundamental properties.
• The interaction between MSCs and microbes is dynamic and context-dependent, with implications for regenerative medicine and infection control.
• Further research is needed to fully understand and harness these interactions for therapeutic applications.